Researchers identified three distinct brain “biotypes” of ADHD, each with its own chemical signature—offering new clues about why treatment can feel like trial and error.

"There is a large placebo effect with high-tech brain therapies, in particular for patients and families that have an expectation that they can adjust brain differences associated with ADHD. It is ...

Attention-deficit/hyperactivity disorder or ADHD translates in different ways across the population, unlike the ...

These brain areas are central to attention and information processing, emotional regulation, executive function and decision-making – all markers of ADHD. "Despite these promising results, this study ...

For years, stimulant medications for ADHD have been described as chemical accelerators, framed as drugs that rev up a sluggish brain. New imaging work turns that story on its head. Brain scans now ...

Roughly 11% of all U.S. children ages 3–17 have been diagnosed with ADHD, or attention-deficit/hyperactivity disorder. That’s the equivalent of two to three ...

Attention-deficit/hyperactivity disorder (ADHD) is often talked about as if it were a single condition. But anyone who works ...

A couple of years ago, Jan Haavik was at a routine meeting of a research group that connects scientists studying attention deficit hyperactivity disorder (ADHD) with people who live with the condition ...

This study found evidence that children with higher screen time exhibit measurable differences in the volume and thickness of several key brain areas. The digital age has fundamentally reshaped ...

Consider the behaviors that constitute the diagnosis: inattention, disorganization, being more active than typical—nothing violent or extreme. The diagnosis doesn’t take into account family or social ...